# PharmaCyte Biotech, Inc.: Form SC 13D/A, filed Jul 11, 2022

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: SC 13D/A
- Filed: 2022-07-11
- Accepted by EDGAR: Jul 11, 2022, 17:11 ET
- Period: not reported
- Accession: 0000921895-22-002213
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000092189522002213/sc13da211375004_07112022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000092189522002213/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000092189522002213/sc13da211375004_07112022.htm

Filed Jul 11, 2022.
Source: SEC EDGAR, the filing index for accession 0000921895-22-002213. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
